Key peptide processing enzymes are expressed by a variant form of small- cell carcinoma of the lung

Peptides

Volumn 19, Issue 10, 1998, Pages 1743-1747

  North, William G ^a   Du, Jinlin ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Carboxypeptidase E; Neuropeptide processing; Peptidylglycine amidating monooxygenase; Prohormone convertase; Small cell carcinoma; Vasopressin

Indexed keywords

ALPHA AMIDATING ENZYME; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CARBOXYPEPTIDASE; FURIN; NEURON SPECIFIC ENOLASE;

ARTICLE; ENZYME ANALYSIS; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MOLECULAR CLONING; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

BLOTTING, WESTERN; CARBOXYPEPTIDASE H; CARBOXYPEPTIDASES; CARCINOMA, SMALL CELL; CLONING, MOLECULAR; FURIN; HUMANS; LUNG NEOPLASMS; MIXED FUNCTION OXYGENASES; MULTIENZYME COMPLEXES; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEQUENCE ANALYSIS, DNA; SUBTILISINS; TUMOR CELLS, CULTURED;

EID: 0032420313     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00130-2     Document Type: Article

References (30)

1. Baylin, S. B.; Weisburger, W. R.; Eggleston, J. C.; Mendelsohn, G.; Beaven, M. A.; Abeloff, M. D.; Ettinger, D. S. Variable content of histaminase, L-dopa decarboxylase, and calcitonin in small-cell carcinoma of the lung. N. Engl. J. Med. 299:105-110; 1978.
2. Carney, D. N.; Gazdar, A. F.; Bepler, G.; Guccion, J. G.; Marangos, P. J.; Moody, T. W.; Zweig, M. H.; Minna, J. D. Establishment and identification of small-cell lung cancer cell lines having classic and variant features. Cancer Res. 45:2913-2923; 1985.
3. Creemers, J. W. M.; Roebroek, A. J. M.; Van de Ven, W. J. M. Expression in human lung tumor cells of the proprotein processing enzyme PC1/PC3: Cloning and primary sequence of a 5 kb cDNA. FEBS Letters. 300:82-88; 1992.
4. el Meskini, R.; Delfino, C.; Boudouresque, F.; Hery, M.; Oliver, C.; Ouafik, L. Estrogen regulation of peptidylglycine alpha-amidating monooxygenase expression in anterior pituitary gland. Endocrinology. 138:379-388; 1997.
5. Fay, M. J.; Friedmann, A. S.; Yu, X.; North, W. G. Vasopressin and vasopressin receptor immunoreactivity in variant and classical small-cell lung carcinoma cell lines: disruption in the activation cascade of V1a-receptors in variant SCCL. Cancer Letters. 82:167-174; 1994.
6. George, J. M.; Capen, C. C.; Phillips, A. S. Biosynthesis of vasopressin in vitro and ultrastructure of a bronchogenic carcinoma. J. Clin. Invest. 51:141-148; 1972.
7. Glauder, J.; Ragg, H.; Rauch, J.; Engels, J. W. Human peptidylglycine alpha-amidating monooxygenase: cDNA, cloning and functional expression of a truncated form in COS cells. Biochem. Biophys. Res. Commun. 169:551-558; 1990.
8. Gregg, D.; Goedken, E.; Gaikin, M.; Wendell, D.; Gorski, J. Decreased expression of carboxypeptidase E protein is correlated to estrogen-induction of rat pituitary tumors. Mol. Cell Endocrinol. 117:219-225; 1996.
9. Grimwood, B. G.; Plummer, T. H. Jr.; Tarentino, A. L. Carboxypeptidase H: a regulatory peptide-processing enzyme produced by human hepatoma Hep G2 cells. J. Biol. Chem. 264:15662-15667; 1989.
10. Hashimoto, K.; Koga M.; Kouhara H.; Arita N.; Hayakawa T.; Kishimoto T.; Sato B. Expression patterns of messenger ribonucleic acids encoding prohormone convertases (PC2 and PC3) in human pituitary adenomas. Clin. Endocrin. 41:185-191; 1990.
11. Hu, H.-M.; Thorn, N. A. Amidating processing enzyme complex for bioactive peptides (PAM) shows differences in specific activity and form in secretory granules isolated from the proximal and distal parts of the hypothalamo-neurohypophyseal tract in rats. FEBS Letters. 324:331-336; 1993.
12. Husten, E. J.; Eipper, B. A. The membrane-bound bifunctional peptidylglycine α-amidating monooxygenase protein. J. Biol. Chem. 266(26): 17004-17010; 1991.
13. Jeng, A. Y.; Fujimoto, R. A.; Chou, M.; Tan, J.; Erion, M. D. Suppression of substance P biosynthesis in sensory neurons of dorsal root ganglion by prodrug esters of potent peptidylglycine alpha-amidating monooxygenase inhibitors. J. Biol. Chem. 272:14666-14671; 1997.
14. Klein, L. A.; Rabson, A. S.; Worksman, J. In vitro synthesis of vasopressin by lung cancer tumor cells. Surg. Forum. 20:231-233; 1969.
15. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685; 1970.
16. Lamango, N. S.; Zhu, X.; Lindberg, I. Purification and enzymatic characterization of recombinant prohormone convertase 2: stabilization of activity by 21 kDa 7B2. Arch. Biochem. Biophys. 330:238-250; 1996.
17. Mania-Farnell, B. L.; Botros, I.; Day, R.; Davis, T. P. Differential modulation of prohormone convertase mRNA by second messenger activators in two cholecystokinin-producing cell lines. Peptides. 17:47-54; 1996.
18. Manser, E.; Fernandez, D.; Loo, L.; Goh, P. Y.; Monfries, C.; Hall, C.; Lim, L. Human carboxypeptidase E: isolation and characterization of the cDNA, sequence conservation, expression, and processing in vitro. Biochem. J. 267:517-525; 1990.
19. Mibikay, M.; Sirois, F.; Seidah, N. G.; Chretien, M. Comparative analysis of expression of the prohormone convertases furin, PACE4, PC1, and PC2 in human lung tumors. Br. J. Cancer. 75:1509-1514; 1997.
20. North, W. G.; Fay, M. J.; Longo, K.; Du, J. Functional V1 vasopressin receptors are present in both variant and classical forms of small-cell tumor cells. Peptides. 18:985-993; 1997.
21. North, W. G.; Fay, M. J.; Longo, K.; Du, J. Expression of all known vasopressin receptor subtypes by small-cell tumors implies a multifaceted role for this peptide. Cancer Research. 58:1866-1871; 1998.
22. North, W. G.; Maurer, L. H.; O'Donnell, J. Human neurophysins and small-cell lung cancer. In: Greco F.A., ed. Biology and management of lung cancer. Boston: Martin Nijhoff Publishers; 1983:143-169.
23. Ohagi, S.; LaMendola, J.; LeBeau, M. M.; Espinosa, R. III.; Takeda, J.; Smeekens, S. P.; Chan, S. J.; Steiner, D. F. Identification of convertase expressed in neuroendocrine tissues. Proc. Natl. Acad. Sci. U.S.A. 89:4977-4981; 1992.
24. Sawyer, W. H. Pharmacological characteristics of the antidiuretic principle in a bronchogenic carcinoma from a patient with hyponatremia. J. Clin. Endocrinol. Metab. 27:1497-1499; 1972.
25. Scopsi, L.; Gullo, M.; Rilke, F.; Martin, S.; Steiner, D. F. Prohormone convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation. J. Clin. Endocrinol. Metab. 80:294-301, 1995.
26. Sharma, S. K.; Boden, J. A.; Springer, C. J.; Burke, P. J.; Bagshawe, K. D. Antibody-directed enzyme prodrug therapy in ovarian tumor xenografts. Cell Biophys. 24-25:219-228; 1994.
27. Song, I.; Fricker, L. Processing of precarboxypeptidase E into carboxypeptidase E occurs in secretory granules. J. Neurochem. 65:444-453; 1995.
28. Song, L.; Fricker, L. D. Purification and characterization of carboxypeptidase D, a novel carboxypeptidase E-like enzyme, from bovine pituitary. J. Biol. Chem. 270:25007-25013; 1995.
29. Wang, W.; Beinfeld, M. C. Cleavage of CCK 33 by recombinant PC2 in vitro. Biochem. Biophys. Res. Commun, 231:149-152; 1997.
30. Zhou, A.; Mains, R. E. Endoproteolytic processing of proopiomelanocortin and prohormone convertase 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 and 2. J. Biol. Chem. 269:17440-17447; 1994.